Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Lambert

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
Blood|December 1, 1995
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumorsR O'Connor, C Liu, C A Ferris, et al.
Journal of Cellular Physiology|October 1, 1989
Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosisV S Goldmacher, C F Scott, J M Lambert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
Humanization of murine monoclonal antibodies through variable domain resurfacingM A Roguska, J T Pedersen, C A Keddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricinT J Lynch, J M Lambert, F Coral, et al.
Protein Engineering|October 1, 1996
A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacingM A Roguska, J T Pedersen, A H Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Eradication of large colon tumor xenografts by targeted delivery of maytansinoidsC Liu, B M Tadayoni, L A Bourret, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
Blood|December 1, 1995
Anti-B4-blocked ricin synergizes with doxorubicin and etoposide on multidrug-resistant and drug-sensitive tumorsR O'Connor, C Liu, C A Ferris, et al.
Journal of Cellular Physiology|October 1, 1989
Cytotoxicity of gelonin and its conjugates with antibodies is determined by the extent of their endocytosisV S Goldmacher, C F Scott, J M Lambert, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1994
Humanization of murine monoclonal antibodies through variable domain resurfacingM A Roguska, J T Pedersen, C A Keddy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricinT J Lynch, J M Lambert, F Coral, et al.
Protein Engineering|October 1, 1996
A comparison of two murine monoclonal antibodies humanized by CDR-grafting and variable domain resurfacingM A Roguska, J T Pedersen, A H Henry, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Eradication of large colon tumor xenografts by targeted delivery of maytansinoidsC Liu, B M Tadayoni, L A Bourret, et al.
Pageof 10